]>
IRCT20200415047082N1 IRCT 2020-04-21 Jahrom University of Medical Sciences Effect evaluation of herbal supplementation from the combination of sugarcane, black myrobalan and mastic along with the treatment protocol of the Ministry of Health on the course of coronavirus disease Effect evaluation of herbal supplementation from the combination of sugarcane, black myrobalan and mastic along with the treatment protocol of the Ministry of Health on the course of COVID-19 disease 2020-05-04 anticipated 70 Complete https://irct.ir/trial/47193 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Randomization method: Simple randomization Randomization unit: individual Randomization tool: from random number table by assigning a code to each patient by the head nurse Allocation concealment: The distribution of herbal supplements in the intervention group and placebo in the control group will be done by nurses based on the randomization result announced by the head nurse. The researcher and nurses will not know the randomization results and the type of package that are being given to the patient. The researcher should only provide the necessary supplement for the intervention and provide it to the head nurse, Blinding description: The distribution of herbal supplements in the intervention group and placebo in the control group will be done by nurses based on the randomization result announced by the head nurse. The researcher and nurses will not know the randomization results and the type of package that are being given to the patient. The researcher should only provide the necessary supplement for the intervention and provide it to the head nurse. 2-3 New Corona virus disease 2019. Intervention 1: Intervention group: Treatment protocol approved by the Ministry of Health during the period of hospitalization + herbal supplement taking from a combination of black myrobalan and mastic and of sugarcane twice a day without water during the period of hospitalization. Intervention 2: Control group: Treatment protocol approved by the Ministry of Health during the period of hospitalization + Placebo taking twice a day Without water during the period of hospitalization. Yes - There is a plan to make this available What will be shared: All potential data will be shared after people get unrecognizable When: Start of access period from 1399 To whom: For public Conditions: Free access Where to obtain: for public How to obtain: by requesting from corresponding writer Comments:
public Alireza Hashemi shiri
Shahid Motahari Ave., University of Medical Sciences, Research Unit
Jahrom Iran (Islamic Republic of) 7414846199 +98 902 001 0987 Entezar14arh@gmail.com Jahrom University of Medical Sciences scientific Esmail Rayat dost
Vali-e-Asr Ave., Peymaniyeh Hospital
Jahrom Iran (Islamic Republic of) 7414846199 +98 71 5427 7145 e.rayat.dost@gmail.com Jahrom University of Medical Sciences Iran (Islamic Republic of) All patients admitted with a diagnosis of COVID-19 COVID-19 patients who are willing to participate in study The patient should not be among high-risk groups, such as breastfeeding or pregnant or etc. Age> 18 years old The patient does not have a specific underlying disease Study 18 years no limit Both People who are under 18 years of age People who are among the high-risk group People who have a specific underlying disease People who are characterized as severe in the illness course U07.1 new Corona virus disease 2019 Treatment - Drugs Placebo Intervention group: Treatment protocol approved by the Ministry of Health during the period of hospitalization + herbal supplement taking from a combination of black myrobalan and mastic and of sugarcane twice a day without water during the period of hospitalization. Control group: Treatment protocol approved by the Ministry of Health during the period of hospitalization + Placebo taking twice a day Without water during the period of hospitalization. Symptoms of disease. Timepoint: During the hospital stay, on a daily basis. Method of measurement: The severity of patient's clinical symptoms is measured on the basis of visual analog scale. Vital Signs. Timepoint: During the hospital stay, on a daily basis. Method of measurement: Vital signs monitoring device. C-Reactive Protein. Timepoint: During the hospital stay, on a daily basis. Method of measurement: C-Reactive Protein test. Pulmonary damages after illness. Timepoint: At the beginning of the study and 14 and 30 days after taking herbal supplements. Method of measurement: Chest Computed Tomography Scan. Jahrom University of Medical Sciences Approved 2020-04-14 Ethics committee of Jahrom University of Medical Sciences Jahrom University of Medical Sciences, Shahid Motahari Ave. Jahrom Fars Iran (Islamic Republic of)